Bay Street News, September, 2020

― Phase III SANET-p demonstrated surufatinib reduces the risk of disease progression or death by 51% in patients with pancreatic […]

MONTRÉAL, 20 sept. 2020 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) offre aux médias la possibilité de s’entretenir […]

MONTREAL, Sept. 20, 2020 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) is offering members of the media the opportunity […]

HOMEWOOD, Ill., Sept. 19, 2020 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) is offering members of the media the […]

Trodelvy achieves a 27 percent overall response rate and a 5.9-month median duration of response in heavily-pretreated patients with metastatic […]

Trodelvy significantly reduced the risk of death by 52 percent, with a median overall survival (OS) of 12.1 months compared […]

The NORA study, presented as a late-breaker oral presentation at the European Society for Medical Oncology (ESMO) 2020 Virtual Congress, […]

HOLLAND LANDING, Ontario, Sept. 18, 2020 (GLOBE NEWSWIRE) — Inscape Corporation (TSX:INQ) (“Inscape” or the “Company”) is pleased to announce […]

SEATTLE, Sept. 18, 2020 (GLOBE NEWSWIRE) — Sound Financial Bancorp, Inc. (Nasdaq: SFBC) (the “Company”), the parent company of Sound […]

NASHVILLE, Tenn., Sept. 18, 2020 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE: HR) today announced that it will redeem […]